Contineum Therapeutics (CTNM) Amortizatization of Intangibles (2023 - 2026)
Contineum Therapeutics' Amortizatization of Intangibles history spans 4 years, with the latest figure at $395000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles rose 69.53% to $395000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Mar 2026, down 68.39% year-over-year, with the annual reading at $1.1 million for FY2025, 72.59% down from the prior year.
- Amortizatization of Intangibles came in at $395000.0 for Q1 2026, up from $392000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $3.2 million in Q4 2024 to a low of -$4000.0 in Q3 2025.
- The 4-year median for Amortizatization of Intangibles is $244000.0 (2024), against an average of $622307.7.
- The largest YoY upside for Amortizatization of Intangibles was 88.11% in 2025 against a maximum downside of 101.73% in 2025.
- Contineum Therapeutics' Amortizatization of Intangibles stood at $2.0 million in 2023, then skyrocketed by 63.17% to $3.2 million in 2024, then tumbled by 87.83% to $392000.0 in 2025, then grew by 0.77% to $395000.0 in 2026.
- Per Business Quant, the three most recent readings for CTNM's Amortizatization of Intangibles are $395000.0 (Q1 2026), $392000.0 (Q4 2025), and -$4000.0 (Q3 2025).